ConvaTec launches new web site on Hydrofiber Technology in Canada

ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced the launch in Canada of a new web site, www.Hydrofiber.ca, demonstrating how the company's proprietary Hydrofiber(R) Technology is transforming wound care.

Designed for clinicians managing chronic and acute wounds, the web site illustrates the unique features and benefits of Hydrofiber(R) Technology with extensive video, data and commentary from research scientists within ConvaTec Wound Therapeutics. This transformational technology, unique to ConvaTec, powers the performance of advanced wound care products, including AQUACEL(R), AQUACEL(R) Ag and Versiva(R) XC(R) dressings, each developed for different wound management needs.

"Hydrofiber(R) Technology is the intelligent choice to meet the diverse wound care needs of clinicians and their individual patients," said Michael Steadman, President of ConvaTec Wound Therapeutics. "This exciting, new online resource shows how our high performance dressings not only help clinicians achieve better outcomes and improve the patient experience, but also contribute to cost control."

ConvaTec dressings with Hydrofiber(R) Technology gel on contact with fluid, providing clinicians and patients with substantial wound care benefits. This unique gelling action enables the dressings to lock in exudate and its harmful components(1-3a) and contour closely to the wound bed,(4a) in response to changing wound conditions. With the addition of ionic silver, AQUACEL(R) Ag dressing also provides "on demand" broad-spectrum antimicrobial activity, responding to increased bacterial load with increased silver ion availability.(5,6a,b)